ASP Isotopes Inc. Common Stock (ASPI)
Automate Your Wheel Strategy on ASPI
With Tiblio's Option Bot, you can configure your own wheel strategy including ASPI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ASPI
- Rev/Share 0.0634
- Book/Share 0.6581
- PB 17.1452
- Debt/Equity 0.9044
- CurrentRatio 7.2118
- ROIC -0.3394
- MktCap 879853156.0
- FreeCF/Share -0.4228
- PFCF -29.9465
- PE -21.5446
- Debt/Assets 0.4231
- DivYield 0
- ROE -0.9658
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ASPI | Canaccord Genuity | -- | Buy | -- | $4.5 | Oct. 4, 2024 |
News
Renergen's Phase 2 EPC Contractor Awarded Preferred Bidder Status
Published: June 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE: GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan.
Read More
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Published: June 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Shareholders to Inquire about Securities Investigation
Published: June 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Could Be The Next Big Nuclear Play
Published: June 05, 2025 by: Seeking Alpha
Sentiment: Positive
AI-driven demand for reliable power is fueling a nuclear renaissance, with Google and tech giants investing heavily in next-gen reactor infrastructure. ASP Isotopes stands out for its isotope enrichment technology, strategic TerraPower partnership, and expansion into advanced materials like Silicon-28. ASPI is a high-risk, high-reward pre-revenue play, with strong cash reserves but significant losses and premium valuation metrics reflecting future growth expectations.
Read More
Renergen's milestone deal shines spotlight on D3 Energy's South African gas potential
Published: June 04, 2025 by: Proactive Investors
Sentiment: Positive
In a significant move for the South African gas industry, Renergen Ltd (ASX:RLT, JSE:REN) on May 22 agreed to a merger with ASP Isotopes (NASDAQ:ASPI), positioning itself as a leading global supplier of critical and enriched industrial gases. The transaction, valued at about $160 million, underscores the growing importance of helium and methane resources.
Read More
ASP Isotopes Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
WASHINGTON, June 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,518,797 shares of its common stock at a price of $6.65 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50.0 million. The offering is expected to close on or about June 3, 2025, subject to the satisfaction of customary closing conditions.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Investors to Connect
Published: May 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Stockholders to Inquire about Securities Investigation
Published: May 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Stockholders to Learn More About the Investigation
Published: May 22, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Investors to Inquire about Securities Investigation
Published: May 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Reach Out
Published: May 15, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes: Proposed Listing And Growth Initiatives To Provide Impetus Into 2026
Published: May 01, 2025 by: Seeking Alpha
Sentiment: Positive
ASP Isotopes Inc.'s secondary listing on the Johannesburg Stock Exchange is expected to enhance liquidity, diversify the shareholder base, and position the company for growth. ASPI's proprietary technology and strategic partnerships, including with TerraPower, validate its capabilities in advanced materials and nuclear power, promising substantial future growth. Despite no revenue guidance for 2025, ASPI's strong cash position and commercialization efforts in isotopes like Carbon-14 and Silicon-28 support a buy rating.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Shareholders to Learn More About the Investigation
Published: April 03, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Published: April 01, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Webinar
Published: March 31, 2025 by: GlobeNewsWire
Sentiment: Neutral
WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), announced that it will release its fourth quarter and fiscal year 2024 financial results after the close of financial markets today, March 31, 2025, with a webinar to follow tomorrow, Tuesday, April 1, 2025 at 10:00 am ET, 3:00 pm UK time, 4:00 pm South African time.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Stockholders to Inquire about Securities Investigation
Published: March 25, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Published: March 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Reach Out
Published: March 18, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Published: March 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Shareholders to Connect
Published: March 06, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Shareholders to Reach Out
Published: March 04, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Published: February 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ASP Isotopes Inc. (NASDAQ: ASPI)
Published: February 20, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Feb. 20, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ASP Isotopes Inc. (NASDAQ: ASPI) on behalf of the company's shareholders. The investigation seeks to determine whether ASP Isotopes's directors breached their fiduciary duties in connection with recent corporate actions.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Investors to Connect
Published: February 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating ASP Isotopes Inc. (ASPI) And Encourages Stockholders to Connect
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI.
Read More
About ASP Isotopes Inc. Common Stock (ASPI)
- IPO Date 2022-11-10
- Website aspisotopes.com
- Industry Chemicals
- CEO Paul Elliot Mann
- Employees 136